Dan L Duncan Comprehensive Cancer Center Launches Phase 1 Clinical Trial Program
August 20, 2024
August 20, 2024
HOUSTON, Texas, Aug. 20 (TNSres) -- The Baylor College of Medicine issued the following news:
Baylor College of Medicine's Dan L Duncan Comprehensive Cancer Center has launched the Albert and Margaret Alkek Foundation Center for Experimental Therapeutics, a Phase 1 clinical trial program that will provide its patients the opportunity to enroll in early phase clinical trials targeting a wide range of malignancies. The program's first trial, which includes a novel therapy targeting a . . .
Baylor College of Medicine's Dan L Duncan Comprehensive Cancer Center has launched the Albert and Margaret Alkek Foundation Center for Experimental Therapeutics, a Phase 1 clinical trial program that will provide its patients the opportunity to enroll in early phase clinical trials targeting a wide range of malignancies. The program's first trial, which includes a novel therapy targeting a . . .